These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34366058)

  • 1. COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
    Paez Vargas JJ; Vidal González A; Pérez-Calvo C; Flandes J
    Chest; 2021 Aug; 160(2):e249. PubMed ID: 34366058
    [No Abstract]   [Full Text] [Related]  

  • 2. In critically ill patients with COVID-19, therapeutic anticoagulation did not increase organ support-free days.
    Donato AA
    Ann Intern Med; 2021 Dec; 174(12):JC135. PubMed ID: 34871054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [COVID-19, anticoagulation and venous thromboembolism: what have we learned ?].
    Blondon M; Robert-Ebadi H
    Rev Med Suisse; 2021 Dec; 17(762):2140-2144. PubMed ID: 34878743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.
    Ramadori G
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation in patients with COVID-19].
    Pekrul I; Spannagl M; Nitschmann S
    Internist (Berl); 2021 Nov; 62(11):1253-1255. PubMed ID: 34636950
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary embolism as a complication of SARS-CoV-2 despite adequate anticoagulation.
    Gomółka P; Biesiada G; Kąkol J; Trąd G; Tyrak KE; Mastalerz L
    Pol Arch Intern Med; 2021 May; 131(5):471-472. PubMed ID: 33769002
    [No Abstract]   [Full Text] [Related]  

  • 8. Empiric Therapeutic Anticoagulation and Mortality in Critically Ill Patients With Respiratory Failure From SARS-CoV-2: A Retrospective Cohort Study.
    Ferguson J; Volk S; Vondracek T; Flanigan J; Chernaik A
    J Clin Pharmacol; 2020 Nov; 60(11):1411-1415. PubMed ID: 32885463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clotting and COVID-19.
    Bull TM
    Chest; 2021 Jun; 159(6):2151-2152. PubMed ID: 34099126
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic Anticoagulation with Heparin in Patients with Covid-19. Reply.
    Zarychanski R; Lawler PR; Goligher E
    N Engl J Med; 2021 Nov; 385(21):2014. PubMed ID: 34788517
    [No Abstract]   [Full Text] [Related]  

  • 11. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients.
    Zhang Y; Cao W; Jiang W; Xiao M; Li Y; Tang N; Liu Z; Yan X; Zhao Y; Li T; Zhu T
    J Thromb Thrombolysis; 2020 Oct; 50(3):580-586. PubMed ID: 32648093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Need for Chemo-Thromboprophylaxis Protocols in Critically Ill COVID-19 Patients.
    Ehrlich H; McKenney M; Elkbuli A
    Am Surg; 2021 May; 87(5):698-699. PubMed ID: 33283541
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulation in COVID-19: DDI Perspective.
    Khiali S; Entezari-Maleki T
    Clin Appl Thromb Hemost; 2020; 26():1076029620959457. PubMed ID: 32936672
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation in COVID-19.
    Bradbury CA; McQuilten Z
    Lancet; 2022 Jan; 399(10319):5-7. PubMed ID: 34921757
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    de Montmollin E; Faille D; Andrieu V; Ajzenberg N; Timsit JF
    J Infect; 2021 May; 82(5):e20-e22. PubMed ID: 33549626
    [No Abstract]   [Full Text] [Related]  

  • 16. Against Therapeutic Anticoagulation in Critically Ill COVID-19 Patients.
    Rizk JG; Lavie CJ; Henry BM
    Semin Thromb Hemost; 2023 Feb; 49(1):79-80. PubMed ID: 36055259
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients.
    Li C; Jiang J; Wang F; Zhou N; Veronese G; Moslehi JJ; Ammirati E; Wang DW
    J Mol Cell Cardiol; 2020 Oct; 147():74-87. PubMed ID: 32827510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    Sterpetti AV
    N Engl J Med; 2021 Nov; 385(21):2013-2014. PubMed ID: 34788516
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic Anticoagulation with Heparin in Patients with Covid-19.
    Fernandes TM; McGuire WC; Morris TA
    N Engl J Med; 2021 Nov; 385(21):2013. PubMed ID: 34788515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.